3 November 2020PatentsJason Romrell, Derek McCorquindale and Brandon Andersen

Arthrex: who are you calling inferior?

On October 13, the US Supreme Court granted certiorari in Arthrex v Smith & Nephew, (case numbers 19-1434, -1452, and -1458). Accordingly, the Supreme Court will now consider whether the Patent Trial and Appeal Board’s (PTAB’s) administrative patent judges (APJs) were unconstitutionally appointed.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

USPTO’s Arthrex guidance offers window into agency’s thinking

26 July 2021 Amid mounting speculation over the uncertainty caused by the US Supreme Court decision’s landmark decision in US v Arthrex, the United States Patent and Trademark Office (USPTO) has posted several updates issuing guidance. But lawyers tell WIPR that some key questions remain.

Patents

Fed Circ reverses Chemours patent invalidations

26 July 2021 The US Court of Appeals for the Federal Circuit has reversed two prior patent invalidation rulings from the US Patent Trial and Appeal Board (PTAB) owned by chemical company Chemours.

Patents

BREAKING: SCOTUS says IPRs should be reviewable in Arthrex; hands more power to USPTO director

21 June 2021 The US Supreme Court has confirmed that judges for the Patent Trial and Appeal Board (PTAB) act as unconstitutional principal officers, and should therefore have been appointed by the President, in its final ruling in United States v Arthrex.

Lululemon counsel on why Nike's 'Flyknit' claim construction faltered

Team of 12 move from Morris Manning to Bradley

WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025

Polsinelli steps up trade practice with hire of former ITC general counsel

Lenovo’s legal leader: We should be ‘enablers, not blockers’

Resilience and the power of brands: Elisabeth Stewart Bradley on 9/11, inclusion and the INTA presidency

Sterlington expands patent litigation team with new hire

‘Now is the time to scale rapidly’: Microsoft supports AI patent tool

Arthrex: who are you calling inferior?

More on this story

Editor's picks

Editor's picks

More articles